Britannica Sources used in this answer

Why do governments sometimes speed up approval of drugs for cancer and AIDS?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

A lab technician wearing protective gloves and face shield lifts a rack of deep-frozen cells from a cryopreservation tank emitting vapor in a laboratory setting. — pharmaceutical industry A technician withdrawing deep-frozen cells for in vitro culture at a laboratory of a German pharmaceutical company.

Governments sometimes expedite the approval of drugs for conditions like cancer and AIDS because of the urgent needs of patients facing serious or life-threatening illnesses. When regulatory processes are perceived as overly restrictive or cautious, individuals with these conditions may be denied or face inordinate delays in accessing potentially life-saving treatments.1

In response to public pressure and the demand for faster access to innovative therapies, regulatory agencies—such as the U.S. Food and Drug Administration—have developed mechanisms to streamline the approval process. These include:12

Accelerated Approval: Allows for consideration based on surrogate endpoints rather than traditional clinical results.2
Fast Track: Enables the rolling submission of clinical data as it becomes available.2
Breakthrough Therapy: Expedites the review of drugs that offer significant improvements over existing treatments.2
Priority Review: Advances the application for review within a shorter timeframe.2

While these measures are essential for addressing unmet medical needs, they reflect a delicate balance in public policy: regulators must weigh the ethical imperative to provide rapid access to hope against the risk of marketing drugs that may possess higher levels of toxicity than the public finds acceptable.1